The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
Open accessAbstract
Challenge of COS1 cells with the adenylyl cyclase activator forskolin led to the activation of recombinant PDE4A8, PDE4B1, PDE4C2 and PDE4D5 cAMP‐specific phosphodiesterase long isoforms. Forskolin challenge did not activate mutant long PDE4 isoforms where the serine target residue (STR) within the protein kinase A (PKA) consensus phosphorylation site in Upstream Conserved Region 1 (UCR1) was mutated to alanine. The PKA inhibitor, H89, ablated forskolin activation of wild‐type long PDE4 isoforms. Activated PKA caused the in vitro phosphorylation of recombinant wild‐type long PDE4 isoforms, but not those where the STR was mutated to alanine. An antiserum specific for the phosphorylated form of the STR detected a single immunoreactive band for recombinant long PDE4 isoforms expressed in COS1 cells challenged with forskolin. This was not evident in forskolin‐challenged cells treated with H89. Neither was it evident in forskolin‐challenged cells expressing long isoforms where the STR had been mutated to alanine. In transfected COS cells challenged with forskolin, only the phosphorylated PDE4D3 long form showed a decrease in mobility in Western blotting analysis. This decreased mobility of PDE4D3 was ablated upon mutation of either of the two serine targets for PKA phosphorylation in this isoform, namely Ser 54 in UCR1 and Ser 13 in the isoform‐specific N‐terminal region. Activation by forskolin challenge did not markedly alter the sensitivity of PDE4A8, PDE4B1, PDE4C2 and PDE4D5 to inhibition by rolipram. Long PDE4 isoforms from all four sub‐families can be phosphorylated by protein kinase A (PKA). This leads to an increase in their activity and may thus contribute to cellular desensitization processes in cells where these isoforms are selectively expressed. British Journal of Pharmacology (2002) 136, 421–433; doi:10.1038/sj.bjp.0704743
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
Soderling, S. H., & Beavo, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00073-3 · Cited by 736
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
AKAPs: from structure to function
Colledge, M., & Scott, J. D. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01558-5 · Cited by 611
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module
Dodge, K. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1921 · Cited by 507
Tailoring cAMP-signalling responses through isoform multiplicity
Houslay, M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01050-5 · Cited by 439
Self-citationThe Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Sette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 409
Microtubules in the Cytoplasm of an Amoeba
HOLBERTON, D. (1969) · Nature · doi:10.1038/222680a0 · Cited by 340
Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity
Xu, R. X., Hassell, A. M., Vanderwall, D., Lambert, M. H., Holmes, W. D., Luther, M. A., Rocque, W. J., Milburn, M. V., Zhao, Y., Ke, H., et al. (2000) · Science · doi:10.1126/science.288.5472.1822 · Cited by 335
Bolger, G., Michaeli, T., Martins, T., St John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., & Ferguson, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6558 · Cited by 315
Houslay, M. D., Sullivan, M., & Bolger, G. B. (1998) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60128-3 · Cited by 290
Self-citationHoffmann, R., Baillie, G. S., MacKenzie, S. J., Yarwood, S. J., & Houslay, M. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.893 · Cited by 270
Self-citationCyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function
Thompson, W. J. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90039-o · Cited by 248
Taskén, K. A., Collas, P., Kemmner, W. A., Witczak, O., Conti, M., & Taskén, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000911200 · Cited by 240
PDE4 cAMP-specific phosphodiesterases
Houslay, M. D. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69049-4 · Cited by 239
Self-citationMacKenzie, S. J., Baillie, G. S., McPhee, I., Bolger, G. B., & Houslay, M. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16609 · Cited by 238
Self-citationDiversity in Cyclic Nucleotide Phosphodiesterase Isoenzyme Families
Manganiello, V. C., Murata, T., Taira, M., Belfrage, P., & Degerman, E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1429 · Cited by 224
Sette, C., Iona, S., & Conti, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37100-4 · Cited by 181
Marchmont, R. J., & Houslay, M. D. (1980) · Biochemical Journal · doi:10.1042/bj1870381 · Cited by 173
Self-citationBaillie, G. S., MacKenzie, S. J., McPhee, I., & Houslay, M. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703636 · Cited by 170
Self-citationHOFFMANN, R., WILKINSON, I. R., McCALLUM, J. F., ENGELS, P., & HOUSLAY, M. D. (1998) · Biochemical Journal · doi:10.1042/bj3330139 · Cited by 165
Self-citationPhosphodiesterase 4 Inhibitors and the Treatment of Asthma
Giembycz, M. A. (2000) · Drugs · doi:10.2165/00003495-200059020-00004 · Cited by 151
The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.
Swinnen, J. V., JOSEPH, D. R., & Conti, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8197 · Cited by 143
MacKenzie, S. J., & Houslay, M. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470571 · Cited by 139
Self-citationBolger, G. B. (1994) · Cellular Signalling · doi:10.1016/0898-6568(94)90018-3 · Cited by 138
Beard, M., Olsen, A. E., Jones, R. E., Erdoğan, S., Houslay, M. D., & Bolger, G. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10349 · Cited by 132
Self-citationShakur, Y., Pryde, J. G., & Houslay, M. D. (1993) · Biochemical Journal · doi:10.1042/bj2920677 · Cited by 131
Self-citationActivation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R. S., Shelton, E. R., & Conti, M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10513-0 · Cited by 129
Erdoğan, S., & Houslay, M. D. (1997) · Biochemical Journal · doi:10.1042/bj3210165 · Cited by 120
Self-citationMcPhee, I., Pooley, L., Lobban, M. D., Bolger, G. B., & Houslay, M. D. (1995) · Biochemical Journal · doi:10.1042/bj3100965 · Cited by 114
Self-citationMcPhee, I., Yarwood, S. J., Scotland, G., Huston, E., Beard, M., Ross, A. H., Houslay, E. S., & Houslay, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11796 · Cited by 108
Self-citationShort Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells
Oki, N., Takahashi, S., Hidaka, H., & Conti, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10831 · Cited by 107
Seybold, J., Newton, R. C., Wright, L. C., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20575 · Cited by 103
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)
Barnette, M. S. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8735-9_5 · Cited by 98
Heyworth, C. M., & Houslay, M. D. (1983) · Biochemical Journal · doi:10.1042/bj2140547 · Cited by 97
Self-citationHuston, E., Lumb, S., Russell, A., CATTERALL, C., ROSS, H. A., STEELE, R. M., Bolger, G. B., PERRY, J. M., Owens, R. J., & Houslay, M. D. (1997) · Biochemical Journal · doi:10.1042/bj3280549 · Cited by 97
Self-citationActivation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation
Lim, J., Pahlke, G., & Conti, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19677 · Cited by 94
Shakur, Y., Wilson, M., Pooley, L., Lobban, M. D., Griffiths, S. L., Campbell, A. M., Beattie, J., Daly, C. J., & Houslay, M. D. (1995) · Biochemical Journal · doi:10.1042/bj3060801 · Cited by 90
Self-citationVicini, E., & Conti, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.7.9941 · Cited by 88
Rena, G., Begg, F., Ross, A. H., MacKenzie, C., McPhee, I., Campbell, L., Huston, E., Sullivan, M., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12557-6 · Cited by 73
Self-citationBaillie, G. S., MacKenzie, S. J., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12520-5 · Cited by 71
Self-citationHuston, E., Beard, M., McCallum, F., Pyne, N. J., Vandenabeele, P., Scotland, G., & Houslay, M. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906144199 · Cited by 52
Self-citationThe Role of Phosphodiesterase Enzymes in Allergy and Asthma
Spina, D., Landells, L. J., & Page, C. P. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60125-8 · Cited by 41
The postsynaptic density: A subcellular anchor for signal transduction enzymes
Klauck, T. M., & Scott, J. D. (1995) · Cellular Signalling · doi:10.1016/0898-6568(95)02003-9 · Cited by 40
Protein kinase A regulation of cAMP phosphodiesterase expression in rat skeletal myoblasts.
Kovala, A. T., Lorimer, I. A. J., Brickenden, A. M., Ball, E. H., & Sanwal, B. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37021-7 · Cited by 29
Cited by
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A
TASKÉN, K., & AANDAHL, E. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00021.2003 · Cited by 775
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Self-citationDISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648
Self-citationMammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Metadata
- Authors
- MacKenzie, S. J., Baillie, G. S., McPhee, I., MacKenzie, C., Seamons, R., McSorley, T., Millen, J., Beard, M. B., van Heeke, G., & Houslay, M. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 136
- Issue
- 3
- Pages
- 421-433
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2004911184
- Cited by
- 260
- References
- 49
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.